Chikungunya Treatment Market Share

On the basis of geographical analysis, the chikungunya treatment market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and the Middle East & Africa region. The market in the Asia Pacific industry is estimated to account for largest revenue share by 2036, driven by growing prevalence of mosquito-transmitted diseases, and rising number of alliances among western market players. Along with these, subsistence of unsanitary conditions in several regions of the Asia is also anticipated to drive APAC’s market growth in the coming years. Additionally, the chikungunya treatment market in North America is expected to acquire the most significant share during the forecast period ascribing to the extensive research and development activities in the healthcare sector, especially in the United States, and presence of well-established healthcare infrastructure in the region. As per the data provided by the Centers for Medicare and Medicaid Services, U.S. health care spending reached USD 3.8 trillion in 2019. As a share of the nation's Gross Domestic Product, health spending accounted for 17.7 percent.